Schroder Investment Management Group
TBIO

Schroder Investment Management Group’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Schroder Investment Management Group’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-183,465
Closed -$5.05M – 1593
2021
Q2 		$5.05M Buy
183,465
+119,042
+185% +$2.34M 0.01% 827
2021
Q1 		$1.06M Sell
64,423
-7,938
-11% -$181K ﹤0.01% 1145
2020
Q4 		$1.33M Buy
+72,361
New +$1.3M ﹤0.01% 1076

Schroder Investment Management Group's TBIO Position: Q3 2021 in Review

Schroder Investment Management Group sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 183,465 shares — an estimated $5.05M sold.

Schroder Investment Management Group first reported a position in TBIO in Q4 2020 and held it in 3 quarters. The position peaked at $5.05M in Q2 2021. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

  • Schroder Investment Management Group reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Schroder Investment Management Group sold 183,465 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $5.05M.
  • Schroder Investment Management Group first reported a position in Translate Bio, Inc. Common Stock in Q4 2020 and held it in 3 quarters.
  • Schroder Investment Management Group's Translate Bio, Inc. Common Stock position peaked at $5.05M in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on Schroder Investment Management Group's 13F filing for Q3 2021, filed 12 Nov 2021.